There is a misconception that targeted cancer therapies (TCT) incite fewer and less-severe toxicities than conventional chemotherapy; receptor crossreactivity between malignant and healthy cells can ...
Kinases have been intensively investigated as drug targets for the past 30 years, with 38 kinase inhibitors approved to date 1. These drugs are predominantly multitargeted receptor tyrosine kinase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback